Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Post by LannyMcdonaldon May 01, 2017 2:23pm
131 Views
Post# 26188075

WHY BIG PHARMA NEEDS TO GET INTO BED WITH DIAGNOS

WHY BIG PHARMA NEEDS TO GET INTO BED WITH DIAGNOSDiabetes Medications are worth $54 Billion Globally.........The market for diabetes drugs will continue to grow quickly. Globally, drug sales have increased between $4 and $5 billion a year for the last 5 years............These medications make up a large proportion of pharmaceutical sales around the world... (for example, they are the second-largest prescription drug class in the U.S.)... Screening a diabetic population for diabetic Retinopathy.. Catches people who need treatment for the disease creating a larger demand for drugs to treat the disease.. Creates more compliant patients leading to a larger demand for other diabetes medications.......WHO IS NUMBER ONE ON THE TOP TEN LIST--NOVO NORDISK--WHO IS ALL OVER BANGLADESH............ITS A WIN WIN......WE SCREEN THEM.....NOVO NORDISK WILL DRUG THEM..!!
Bullboard Posts